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Abstract
This study was achieved at the industrial kidney center in Qatan hospital during the period from February 2018 to
July 2018, the study aimed at evaluating some hematological changes that occur in patients with chronic renal failure
(CRF) undergoing hemodialysis and comparing them with healthy people. Blood sample of 55 cases of both sexes
were collected: 35 patients with CRF and on regular maintenance dialysis, and a control group of 20 healthy persons
for comparison, in the age group ranged between 25-70 years for both groups. Hemoglobin concentration, total red
cells count, packed cell volume, total white blood cells count, neutrophils and lymphocytes differential count and
platelets count were assessed by using Sysmex hematology analyzer. Data was analyzed through statistical package
for social sciences (SPSS) version 24. Results recorded a significant decrease (p<0.05) in Hemoglobin concentration,
total red cells count, packed cell volume and platelets count in patients with CRF compared to the healthy group.
Although the total white blood cells count did not record any significant change, the differential count of
lymphocytes decreased significantly (p<0.05), and the differential count of neutrophils increased without significant
differences in patients with chronic renal failure CRF compared to healthy subjects. In conclusion, the present
findings suggested that the chronic renal failure CRF had a negative effect in most of hematological parameters under
study. Therefore, hematological parameters that need careful evaluation and management in chronic renal failure
CRF patients.
Keywords: Chronic renal failure, Hemodialysis, Hematological changes, Hadhramout.

Introduction:
Nearly 2.6 million patients worldwide have
different kidney diseases [17], kidney failure is
one of this kidney diseases. When kidney failure
becomes chronic, the kidneys slowly stop
functioning [29]. Renal failure is defined as a
condition in which the kidneys are not able to do
their normal functions in filtering blood from
impurities and secondary body products [33],
which lead to the accumulation of wastes and
fluid in the body [11].
Hemodialysis (HD) is one of the replacement
therapy for chronic kidney disease; using HD
involves the elimination of excessive toxic fluids
and toxic metabolic end products from the body
[26]. HD procedure is performed two to three times
a week over two to four hours. The duration of
dialysis varies according to many factors, including
kidney function, amount of waste in the body, level
of salts, as well as body weight [30].
Kidney failure affects different body organs, and
among these effects: The effect on blood variables,
as anemia is one of the most important symptoms
of kidney failure [10], it leads to a decrease in the
number of total red cells count (RBCs),
Hemoglobin concentration (HB), and packed cell
volume (PCV) [19, 21], as well as reduced the
mean cell volume (MCV), mean corpuscular
hemoglobin (MCH), and mean corpuscular
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hemoglobin concentration (MCHC) [22].
As there is limited literature regarding the
hematological profile of patients with chronic
renal failure (CRF) in Hadhramout- Yemen, this
study aimed at assessing hematological
parameters in patient of CRF and comparing
them with healthy person results.
Material and Methods:
Study design, area, and period
This analytical cross-sectional study was carried
out at the industrial kidney center in Qatan
hospital , Hadhramout governorate – Yemen ,
during the period from February 2018 to July
2018.
Study population
Two study groups were involved: Case and
control groups. Case group includes 35 patients
with CRF undergoing hemodialysis (22 males
and 13 females). The control group was selected
for comparison which includes 20 healthy
subjects (14 males and 6 females), who were
similar with cases in age and sex (age group
ranged between 25-70 years for both groups).
Samples collection and laboratory analysis
Venous blood samples (2.5 ml) were collected
from all participants (patients and healthy persons)
in ethylene diamine tetra acetic acid (EDTA) tube
for investigation of hematological parameters:
RBCs count, HB concentration, PCV, PLT count,
WBCs count and differential count of NEUT and
LYM using automatic hematology analyzer
(Sysmex KX-21, 2000, Japan).
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as compared to the healthy group. Despite the
significant decrease in the PLT count in CRF
patients, they are still within the normal values.
Also, Table 1 indicates that there are no
significant differences in the mean values of the
total WBCs counts in patients with CRF
compared with healthy subjects, and that there
are differences in the mean values of the
differential of WBCs; the differential count of
NEUT increased without significant differences,
and the differential count of LYM decreased
significantly (p<0.05) in patients with CRF
compared to healthy subjects, Figure 3.

Ethical consideration:
Consent form was taken from all the participants
after brief description of the study.
Statistical analysis:
The SPSS, version 24.0 program was used in this
study. The study data was expressed using Mean
± Standard Deviation (SD). The t- test for
independent variables was considered significant
when (p> 0.05).
Results:
Table 1 shows that there was a significant
decrease (p<0.05) in the mean values of RBCs
mass (HB level, RBCs count, PCV) Figure 1,
and PLT count Figure 2 in group of CRF patients

Table 1: Hematological parameters (HB concentration, RBCs count, PCV,
and PLT count) between the two study groups
Standard division) ±Mean ) Hematological parameters
Groups

Healthy group

Patients group
P-value (Sig)

HB
g/dl

RBCs
106/ μl

PCV
%

PLT
103/ μl

14.6 ± 0.6

4.8 ± 0.3

39.07 ± 1.6

320 ± 60

WBCs
103/ μl

0.021

0.01

0.04

0.06

56.5 ±5.3 27.3 ±4.4*
0.37

P-value <0.05 Significant at *

Figure (1): Shows the RBCs mass (HB concentration, RBCs count,
and PCV %) between two study groups

196

LYM
%

6.9 ±0.9 55.7 ±4.07 29.9 ±3.2

*9.95 ± 0.31 *3.8 ± 0.48 30.9 ± 4.2** *190 ± 44 6.7 ±1.6
0.015

NEUT
%

0.045
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Figure (2): Shows PLT count between two study groups

Figure (3): Shows WBCs count and differential Neut and
Lym between two study groups
Discussion:
CRF stays with the individual afflicted with it
throughout his life, and the disease poses a threat to
the lives of patients, and often causes death if it is
not dealt with carefully and the recommendations
of specialists in this field are followed.
The results of this study showed a significant
decrease in the RBCs mass (HB concentration,
RBCs count, PCV) in patients with CRF who
were subjected to hemodialysis comparing the
healthy persons, and these results were consistent
with the results of many studies conducted on
patients with CRF in some countries, including:
the study from Saudi Arabia [1], study from
Sudan [34], study from India [19], and the study
from Pakistan [21]. Many studies have indicated
that anemia is a common complication associated

with CRF. This is achieved through a decrease in
HB concentration, RBCs counts, and PCV [6, 10,
21]. Anemia results in patients with CRF from a
low level of erythropoietin (EPO) hormone [24]
responsible for stimulating mothers of RBCs,
(hemocytoblast) in the bone marrow, to produce
and regulate RBCs, and this hormone is
produced from intermediate cells in the kidney
[32], as the interstitial cells around the renal
tubules are responsible for secreting 85-90% of
the hormone in adult human [27].
There are also other causes of anemia in patients
with CRF, including blood loss during the HD
process, and the lack of iron, folic acid and vitamin
B12 levels resulting from malnutrition that patients
often suffer from kidney failure [16], in addition to
decrease in the duration of RBCs remaining in the
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bloodstream is inversely proportional to the
concentration of urea and nitrogen in the blood,
which in turn improves significantly after intensive
dialysis in patients. It has been found through
previous studies that blood urea leads to an increase
in the expression of phosphatidylserine on the outer
surface RBCs, which in turn enhances the
distinction of RBCs by macrophages, and
subsequently leads to their destruction and a
decrease in their survival [5]. Anemia in patients
with CRF may also be attributed to the increased
secretion of parathyroid hormone, which causes
damage to the bone marrow [2].
The National Kidney Foundation Kidney Disease
Outcomes Quality Initiative (NKF-K / DOQI)
determined the required HB concentration in
patients with renal failure at 11-12 mg/dl [23],
which is higher than the HB concentration in
patients with CRF in this study (9.9 mg/dl), this
finding indicated that anemia in patients with
CRF was moderate in this study, and that may
have been a result of giving many patients an
injection of EPO hormone. One of the important
reasons that led to the low of HB concentration is
the deficiency of the iron element that enters the
chemical composition of the HB molecule, and
this deficiency results due to malnutrition
suffered by patients with CRF on the one hand,
and to inhibit the absorption of iron from the
intestine due to high level of immune cytokines
on the other hand [13].
The results of this study showed that there is a
significant decrease in PCV in patients with CRF
compared with healthy people, and this is
consistent with some studies, that were
conducted in Saudi Arabia [1], Libya [15] and
Pakistan [21], and this is due to the decrease in
the RBCs count and HB concentration, as the
PCV is directly proportional to the RBCs count,
or due to an increase in body water due to
uremia, which retains the largest amount of
water. A study published in the Brazilian Journal
of Hematology and Hemotherapy [4] has
indicated that the decrease in HB concentration
and PCV is due to a lack of EPO hormone, the
hormone is responsible for the formation of
RBCs from the bone marrow, and that a lack of
RBCs leads to a decrease in HB and PCV.
It was observed in this study that a significant
decrease in the PLT count occurred in patients
with CRF compared with the healthy people
group, and this decrease was consistent with
published studies [10, 21], and this may be due to
the accumulation of nitrogenous compounds in the
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blood. As nitrogenous wastes inhibit the PLT
formation process in the bone marrow, as well as
increase the acidity of the blood, it was found that
there is an inverse relationship between the acidity
of the blood and PLT, and this is consistent with
the findings of other studies [3, 10, 18].
Researchers [9] indicated that the low PLT count
is due to the lack of secretion of EPO hormone,
because EPO levels can affect the PLT count.
It is known that WBCs originate from stem cells
in the bone marrow, just like RBCs [7]. NEUT
makes up the largest part of WBCs, with a
percentage of 70-50%. NEUT cells are newly
formed remain in the bloodstream between 10-7
hours, after which they pass into the tissues [8].
As for the percentage of LYM, it is between 2040% of the total WBCs [31]. The increase in
NEUT cells indicates the presence of a bacterial
inflammatory condition, as these cells spend
most of their lives in connective tissues [28].
This study showed a decrease in the total WBCs
count in patients with CRF compared with the
healthy group, with no significant differences,
and this is consistent with the results of other
study [32], and differs from the results of other
studies [1, 12]. A study result [25] explained that
the decrease in the total number of WBCs is due
to two reasons: decrease in the manufacture of
WBCs by the bone marrow as a result of
inflammation and high concentration of proinflammatory cytokines, which inhibit the
production of WBCs in bone marrow.
The results of this study showed that there is a
significant decrease in the percentage of LYM in
patients with CRF compared with healthy people, and
this may be attributed to an increase in the rate of
apoptosis of LYM, due to the accumulation of
nitrogenous waste products. In turn, the decrease in
LYM leads to a decrease in the total number of WBCs
[20]. It was also evident from this study that an
increase percentage of NEU cells in patients with CRF
compared with healthy people, with no significant
differences, and these results were in agreement with
the findings the other study's findings [14]. This is due
to the case of uremia, as well as HD treatment, as it
leads to an increase in the number of NEU cells and
mononuclear cells in response to any stimulus that
leads to inflammation [14].
Conclusion: Chronic renal failure CRF is
associated with different degrees of abnormality
in hematological parameters. So, hematological
parameters in chronic renal failure CRF patients
need careful evaluation and management.
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مجمة جامعة حضرموت لمعموم الطبيعية والتطبيقية المجمد ,71العدد  ,2ديسمبر 2222م

تقويم بعض التغريات الدموية عند مرضى الفشل الكلوي املزمن
يف مستشفى القطن ,حمافظة حضرموت -اليمن
دمحم عمي المسيمي

عبدالرحمن سالم ياسين
الممخص

أجريت الدراسة الحالية في مركز الك مى الصناعي بمستشفى القطن خالل الفترة من فبراير  2018إلى يوليو  ,2018ورمت إلى تقويم

بعض التغيرات الدموية التي تحدث عند مرضى الفشل الكموي المزمن الذين يخضعون لغسيل الكمى ومقارنتها مع أشخاص أصحاء.

جمعت  55عينة دم من كال الجنسين ,منها  35مريضا بالفشل الكموي المزمن والذين يخضعون دوريا لجمسات الغسيل الدموي ,ومجموعة
ضابطة قوامها  20شخصا سميما لممقارنة ,في فئة عمرية تراوحت بين  70 -25سنة لكال المجموعتين .تم تقويم تركيز الهيموجموبين,
العدد الكم ي لمخاليا الحمراء ,نسبة الهيماتوكريت ,العد الكمي لخاليا الدم البيضاء ,العد التفاضمي لخاليا العدتات والخاليا الميمفاوية ,فضال
عن عدد الصفائح الدموية وذلك باستخدام جهاز محمل الدم  . Sysmexحممت البيانات إحصائيا من خالل الحزمة اإلحصائية لمعموم

اتاجتماعية ( )SPSSاإلصدار  .24سجمت التحميالت اإلحصائية لمنتائج انخفاض معنوي ) (p<0.05في مستوى الهيموجموبين ,عدد
خاليا الدم الحمراء  ,تركيز الهيماتوكريت وعدد الصفائح الدموية عند مرضى الفشل الكموي المزمن مقارنة بالمجموعة الضابطة .عمى الرغم
من أن إجمالي عدد خاليا الدم البيضاء لم يسجل أي تغيير معنوي  ,إتا أن العدد التفاضمي لمخاليا الميمفاوية انخفض معنويا ),(p<0.05

وزاد العدد التفاضمي لمعدتات دون وجود فروق ذات دتالة إحصائية عند مرضى الفشل الكموي المزمن مقارنة باألشخاص األصحاء.

يستنتج من الدراسة أن الفشل الكموي المزمن كان له تأثير سمبي في معظم متغيرات الدم قيد الدراسة .لذلك ,تحتاج المتغيرات الدموية إلى
تقويم وادارة دقيقين عند مرضى الفشل الكموي المزمن.

الكممات المفتاحية :الفشل الكموي المزمن ,الغسيل الدموي ,التغيرات الدموية ,حضرموت.
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